サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1744923

急性脊髄損傷の世界市場

Acute Spinal Cord Injury

出版日
ページ情報
英文 274 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
急性脊髄損傷の世界市場
出版日: 2025年06月06日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 274 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

急性脊髄損傷の世界市場は2030年までに87億米ドルに達する見込み

2024年に67億米ドルと推定される急性脊髄損傷の世界市場は、2024年から2030年にかけてCAGR 4.5％で成長し、2030年には87億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである完全脊髄損傷は、CAGR 5.2%を記録し、分析期間終了時には62億米ドルに達すると予測されます。不完全脊髄損傷セグメントの成長率は、分析期間中CAGR 2.9%と推定されます。

米国市場は18億米ドルと推定、中国はCAGR 8.3％で成長予測

米国の急性脊髄損傷市場は、2024年に18億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに18億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは8.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.8％と3.5％と予測されています。欧州では、ドイツがCAGR 2.6%で成長すると予測されています。

世界の急性脊髄損傷（SCI）治療市場- 主要動向と促進要因まとめ

急性脊髄損傷が救急、外傷、神経リハビリテーション医療において重要な治療優先課題である理由とは？

急性脊髄損傷（SCI）は、突発的、外傷的な出来事により、損傷部位より下の感覚、運動、自律神経機能が部分的または完全に障害されるものです。SCIは最も複雑で壊滅的な神経学的緊急事態の1つであり、多くの場合、交通事故、転倒、スポーツ外傷、暴力などによって生じる。虚血、炎症、興奮毒性によって引き起こされる不可逆的な二次障害は、最初の外傷に続いて急速に起こり、長期的な障害を悪化させるため、早急な介入が不可欠です。

社会的・経済的負担が大きいため、急性期SCIは世界的に外傷や神経外科のプロトコールでますます優先されるようになっています。早期発見、外科的安定化、エビデンスに基づく薬理学的およびリハビリテーション戦略は、機能的転帰を最大化し、合併症を減少させ、罹患者の生活の質を改善するために不可欠です。

外科的介入、薬物療法、神経保護における革新は、SCIケアをどのように前進させているか？

外科的除圧術と安定化術は、技術の進歩により、より正確で低侵襲なアプローチが可能となり、手術リスクを軽減し、早期の可動化を支援する、依然として根幹をなす治療法です。脊髄ナビゲーション、術中画像診断、神経モニタリングは、アライメントの精度を高め、異所性損傷を最小限に抑えることで、手術成績を向上させています。

一部の症例における高用量メチルプレドニゾロンを含む薬理学的アプローチが再評価される一方で、新たな神経保護療法は炎症、アポトーシス、酸化ストレスを標的としています。リルゾール、ミノサイクリン、幹細胞由来の生物製剤など、2次障害を抑制し神経再生を促進する薬剤の調査が進んでいます。これと並行して、集中的なリハビリテーションや、外骨格や電気刺激装置などの支援技術が、神経可塑性と機能回復を高めています。

急性期SCI治療の需要を牽引している患者層とヘルスケアシステムは？

若年成人男性は、危険な活動にさらされる機会が多いため、世界的に急性脊髄損傷症例の大きな割合を占めています。しかし、人口の高齢化は、特に先進国において、衝撃の少ない転倒によるSCIの増加に寄与しています。救急部、外傷センター、専門の神経リハビリテーション部が主要なケアポイントであり、長期的な管理には集学的なフォローアップと地域に根ざした支援が必要なことが多いです。

北米は、発生率の追跡、高度な外傷対応システム、急性期後のケアインフラの利用可能性という点でリードしています。欧州は、強固な神経リハビリテーション・プログラムとSCI治療薬の臨床試験が進行中です。アジア太平洋は、急速な都市化と自動車事故の増加の中、症例数の増加を目の当たりにしており、外傷治療と脊椎手術能力への地域的投資を促進しています。ラテンアメリカとアフリカの一部では、早期介入と長期的支援における格差が依然として重大な課題です。

医療政策、研究資金、支援技術は市場開拓にどのような影響を与えているか？

SCIが公衆衛生上の問題であるという政策レベルの認識により、救急医療サービス、手術能力、長期的リハビリテーションへの投資が加速しています。全国的な外傷登録、臨床ガイドライン、SCIセンター・オブ・エクセレンスへの資金援助は、標準化されたケアの提供と研究への参加を促進しています。外科的介入、リハビリテーション、移動補助具の保険適用もいくつかの地域で改善され、治療へのアクセスが拡大しています。

SCI調査、特に神経再生、脊髄インプラント、先進リハビリテーション・ロボティクスに多額の資金が向けられている。学術界、バイオテクノロジー企業、政府機関の協力体制が、臨床革新の限界を押し広げています。ウェアラブル補助装置、ブレイン・コンピュータ・インターフェイス、神経補綴は、脊髄損傷者の自立と回復に新たな局面をもたらし、統合治療経路の将来的な機会を創出しています。

急性期SCI治療市場の成長を促進する要因は何か？

急性期SCI治療市場は、世界の外傷発生率の増加、意識の高まり、緊急対応システムの改善、外科手術と神経保護戦略の急速な進歩により拡大しています。また、専門的な神経リハビリテーション・サービスの利用可能性の高まりや、機能回復をサポートする支援技術の革新も成長を支えています。臨床ガイドラインが進化し、研究の飛躍的進歩が加速するにつれて、急性期SCIに対する標準治療は重要な変革期を迎えています。

今後、市場の軌跡は、新たな治療法、手術の革新、長期的ケアモデルが、転帰の改善と自律性の回復にいかに効果的に融合するかによって形成されるであろう。脊髄の再生と機能回復に世界の注目が集まる中、急性期SCI治療が次世代の神経外傷・リハビリテーション医療の礎石となる可能性はあるのだろうか。

セグメント

タイプ（完全脊髄損傷、不完全脊髄損傷）、エンドユース（病院、外傷センター）

調査対象企業の例（全43件）

  • AbbVie Inc.
  • Acorda Therapeutics, Inc.
  • Asterias Biotherapeutics, Inc.
  • Athersys, Inc.
  • Axoltis Pharma
  • BioArctic AB
  • BioAxone BioSciences, Inc.
  • BioTime, Inc.
  • Geron Corporation
  • Histocell S.L.
  • InVivo Therapeutics Holdings Corp
  • Kringle Pharma, Inc.
  • Lineage Cell Therapeutics, Inc.
  • Merz Therapeutics
  • Mitsubishi Tanabe Pharma Corp.
  • Neuralstem, Inc.
  • Neuronax SA
  • Novartis AG
  • Onward Medical
  • Paradromics, Inc.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP34544

Global Acute Spinal Cord Injury Market to Reach US$8.7 Billion by 2030

The global market for Acute Spinal Cord Injury estimated at US$6.7 Billion in the year 2024, is expected to reach US$8.7 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Complete Spinal Cord Injury, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$6.2 Billion by the end of the analysis period. Growth in the Incomplete Spinal Cord Injury segment is estimated at 2.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.8 Billion While China is Forecast to Grow at 8.3% CAGR

The Acute Spinal Cord Injury market in the U.S. is estimated at US$1.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 8.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Global Acute Spinal Cord Injury (SCI) Treatment Market - Key Trends & Drivers Summarized

Why Is Acute Spinal Cord Injury a Critical Therapeutic Priority in Emergency, Trauma, and Neurorehabilitation Medicine?

Acute spinal cord injury (SCI) is a sudden, traumatic event resulting in partial or complete disruption of sensory, motor, and autonomic functions below the injury site. It represents one of the most complex and devastating neurological emergencies, often arising from vehicular accidents, falls, sports injuries, or violence. Immediate intervention is vital, as irreversible secondary damage-driven by ischemia, inflammation, and excitotoxicity-can rapidly follow the initial trauma, exacerbating long-term disability.

With high societal and economic burden, acute SCI is increasingly prioritized in trauma and neurosurgical protocols worldwide. Early recognition, surgical stabilization, and evidence-based pharmacologic and rehabilitative strategies are essential to maximizing functional outcomes, reducing complications, and improving quality of life for affected individuals.

How Are Innovations in Surgical Intervention, Pharmacotherapy, and Neuroprotection Advancing SCI Care?

Surgical decompression and stabilization remain cornerstone treatments, with technological advances enabling more precise and minimally invasive approaches that reduce operative risk and support early mobilization. Spinal navigation, intraoperative imaging, and neuro-monitoring are improving surgical outcomes by enhancing alignment accuracy and minimizing iatrogenic damage.

Pharmacological approaches, including high-dose methylprednisolone in select cases, are being reassessed, while emerging neuroprotective therapies are targeting inflammation, apoptosis, and oxidative stress. Research is advancing into agents such as riluzole, minocycline, and stem cell-derived biologics to limit secondary damage and promote neuroregeneration. In parallel, intensive rehabilitation and assistive technologies such as exoskeletons and electrical stimulation devices are enhancing neuroplasticity and functional recovery.

Which Patient Demographics and Healthcare Systems Are Driving Demand for Acute SCI Treatment?

Young adult males account for a large proportion of acute SCI cases globally due to their higher exposure to risk-prone activities. However, aging populations are contributing to a rise in SCI from low-impact falls, especially in developed countries. Emergency departments, trauma centers, and specialized neurorehabilitation units are the primary points of care, with long-term management often requiring multidisciplinary follow-up and community-based support.

North America leads in terms of incidence tracking, advanced trauma response systems, and availability of post-acute care infrastructure. Europe follows with robust neurorehabilitation programs and ongoing clinical trials in SCI therapeutics. Asia-Pacific is witnessing rising caseloads amid rapid urbanization and increasing motor vehicle accidents, driving regional investments in trauma care and spinal surgery capabilities. In Latin America and parts of Africa, gaps in early intervention and long-term support remain critical challenges.

How Are Health Policies, Research Funding, and Assistive Technologies Influencing Market Development?

Policy-level recognition of SCI as a public health concern is accelerating investment in emergency medical services, surgical capacity, and long-term rehabilitation. National trauma registries, clinical guidelines, and funding for SCI centers of excellence are facilitating standardized care delivery and research participation. Insurance coverage for surgical intervention, rehabilitation, and mobility aids is also improving in several regions, expanding treatment access.

Significant funding is being directed toward SCI research, particularly in neuroregeneration, spinal cord implants, and advanced rehabilitation robotics. Collaborative efforts between academia, biotech firms, and government agencies are pushing the boundaries of clinical innovation. Wearable assistive devices, brain-computer interfaces, and neuroprosthetics are offering new dimensions of independence and recovery for individuals with SCI, creating future opportunities for integrated treatment pathways.

What Are the Factors Driving Growth in the Acute SCI Treatment Market?

The acute SCI treatment market is expanding due to increasing global trauma incidence, heightened awareness, improved emergency response systems, and rapid advancements in surgical and neuroprotective strategies. Growth is also supported by the rising availability of specialized neurorehabilitation services and innovation in assistive technologies that support functional restoration. As clinical guidelines evolve and research breakthroughs accelerate, the standard of care for acute SCI is undergoing meaningful transformation.

Looking ahead, the market’s trajectory will be shaped by how effectively emerging therapies, surgical innovations, and long-term care models converge to improve outcomes and restore autonomy. As global focus intensifies on spinal cord regeneration and functional recovery, could acute SCI treatment become a cornerstone of next-generation neurotrauma and rehabilitation medicine?

SCOPE OF STUDY:

The report analyzes the Acute Spinal Cord Injury market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Complete Spinal Cord Injury, Incomplete Spinal Cord Injury); End-Use (Hospitals, Trauma Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • AbbVie Inc.
  • Acorda Therapeutics, Inc.
  • Asterias Biotherapeutics, Inc.
  • Athersys, Inc.
  • Axoltis Pharma
  • BioArctic AB
  • BioAxone BioSciences, Inc.
  • BioTime, Inc.
  • Geron Corporation
  • Histocell S.L.
  • InVivo Therapeutics Holdings Corp
  • Kringle Pharma, Inc.
  • Lineage Cell Therapeutics, Inc.
  • Merz Therapeutics
  • Mitsubishi Tanabe Pharma Corp.
  • Neuralstem, Inc.
  • Neuronax SA
  • Novartis AG
  • Onward Medical
  • Paradromics, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Acute Spinal Cord Injury - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Road Accidents and Sports Injuries Throws the Spotlight on Acute Spinal Cord Injury (SCI) Treatment
    • Growing Availability of Emergency Neurotrauma Services Spurs Demand for Immediate SCI Interventions
    • Integration of High-Resolution MRI and Imaging Tools Enhances Acute SCI Diagnosis and Prognosis
    • Development of Exoskeletons and Neuromodulation Devices Bodes Well for SCI Rehabilitation Options
    • Expanding Use of Clinical Decision Support Tools Improves Acute Care Protocols in SCI Cases
    • Focus on Multidisciplinary Acute Care Models Spurs Innovation in SCI Treatment Planning
    • Growth in Clinical Trials for Anti-Inflammatory and Neuroprotective Agents Sets the Stage for Market Disruption
    • Rising Emphasis on Minimizing Secondary Injury Risks Fuels Demand for Early-Stage Interventions
    • Emergence of Targeted Drug Delivery Systems Enhances Precision in Acute SCI Pharmacologic Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Acute Spinal Cord Injury Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Acute Spinal Cord Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Acute Spinal Cord Injury by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Complete Spinal Cord Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Complete Spinal Cord Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Complete Spinal Cord Injury by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Incomplete Spinal Cord Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Incomplete Spinal Cord Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Incomplete Spinal Cord Injury by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Trauma Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Trauma Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Trauma Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Acute Spinal Cord Injury Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Acute Spinal Cord Injury Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Japan 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Acute Spinal Cord Injury Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: China 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Acute Spinal Cord Injury Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Acute Spinal Cord Injury by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Europe 15-Year Perspective for Acute Spinal Cord Injury by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Acute Spinal Cord Injury Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: France 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Acute Spinal Cord Injury Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Germany 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Italy 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Acute Spinal Cord Injury Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: UK 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Spain 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Russia 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Acute Spinal Cord Injury Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Acute Spinal Cord Injury by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 15-Year Perspective for Acute Spinal Cord Injury by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Acute Spinal Cord Injury Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Australia 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Acute Spinal Cord Injury Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: India 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: South Korea 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Acute Spinal Cord Injury Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Acute Spinal Cord Injury by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Latin America 15-Year Perspective for Acute Spinal Cord Injury by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Argentina 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Brazil 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Mexico 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Latin America 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Acute Spinal Cord Injury Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Acute Spinal Cord Injury by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Middle East 15-Year Perspective for Acute Spinal Cord Injury by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Iran 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Israel 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Saudi Arabia 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: UAE 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Middle East 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Acute Spinal Cord Injury Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Acute Spinal Cord Injury by Type - Complete Spinal Cord Injury and Incomplete Spinal Cord Injury Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Africa 15-Year Perspective for Acute Spinal Cord Injury by Type - Percentage Breakdown of Value Sales for Complete Spinal Cord Injury and Incomplete Spinal Cord Injury for the Years 2015, 2025 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Acute Spinal Cord Injury by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Acute Spinal Cord Injury by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2015, 2025 & 2030

IV. COMPETITION